Successful Therapeutic Plasma Exchange Therapy In Severe Tetanus
Abstract
Introduction: Tetanus is an acute toxemia condition caused by neurotoxin produced by Clostridium tetani manifested as periodic muscular spasm. Manifestation could range from localized tetanus into generalized tetanus and cephalic tetanus. Severe forms of tetanus complicating management and mostly resulted in death because of asphyxia and hyperactivity of sympathetic system. Therapeutic plasma exchange (TPE), in which plasma separated from whole blood and replaced with normal saline, albumin, or fresh frozen plasma, could improve survival in toxemia condition although studies about the use of TPE in the treatment of tetanus still lacking.
Case Illustration: A man in his 60s presented to the ER with complaint of generalized stiffness on belly, legs, arms and jaw in which the patient hardly open his mouth. Patient was diagnosed with tetanus due to history of unhealed wound on patient’s left pinky toe two weeks prior. Patient condition worsened through period of admission that requiring intensive care and mechanical ventillation on fifth day after admission. Two TPE therapy on fifth and eighth day of admission was given with improvement of patient’s clinical condition after two days of second TPE therapy.
Discussion: Indication of TPE has expanded, and severe tetanus could be indicated as one of TPE indications inline with principle of management of tetanus to prevent the spread and toxicity of neurotoxins. The general principle of TPE is to remove a circulating molecule from the blood in the hope of improving the clinical condition of the patient.
Conclusion: Tetanus is pretty common case in developing countries related to high mortality rate. Management of severe tetanus could be tricky in several case. Therapeutic plasma eschange (TPE) may be a better therapeutic alternatives with some successful use reported in treatment of neurological cases.
Keywords
Full Text:
PDFReferences
Megighian A, Pirazzini M, Fabris F, Rossetto O, Montecucco C. Tetanus and tetanus neurotoxin: From peripheral uptake to central nervous tissue targets. J Neurochem. 2021 Sep 14;158(6):1244–53.
Clarissa Tertia, I Ketut Sumada, Ni Ketut Candra Wiratmi. Laporan Kasus: Tetanus Tipe General pada Usia Tua Tanpa Vaksinasi. Callosum Neurology. 2019 Aug 31;2(3):9–10.
Li J, Liu Z, Yu C, Tan K, Gui S, Zhang S, Shen Y. Global epidemiology and burden of tetanus from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. International Journal of Infectious Diseases. 2023 Jul;132:118–26.
Fan Z, Zhao Y, Wang S, Zhang F, Zhuang C. Clinical features and outcomes of tetanus: a retrospective study. Infect Drug Resist. 2019 May;Volume 12:1289–93.
Arifin H, Widiasih R, Pradipta RO, Kurniawati Y. Regional disparities and their contribution to the coverage of the tetanus toxoid vaccine among women aged 15–49 years in Indonesia. F1000Res. 2021 Aug 31;10:437.
Mcelaney P, Iyanaga M, Monks S, Michelson E. The Quick and Dirty: A Tetanus Case Report. Clin Pract Cases Emerg Med. 2019 Jan 22;3(1):55–8.
Fernández-Zarzoso M, Gómez-Seguí I, de la Rubia J. Therapeutic plasma exchange: Review of current indications. Transfusion and Apheresis Science. 2019 Jun;58(3):247–53.
Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018 Dec 30;22(1):285.
Rossetto O, Montecucco C. Tables of Toxicity of Botulinum and Tetanus Neurotoxins. Toxins (Basel). 2019 Nov 22;11(12):686.
Pirazzini M, Montecucco C, Rossetto O. Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update. Arch Toxicol. 2022 Jun 25;96(6):1521–39.
Proux‐Gillardeaux V, Rudge R, Galli T. The Tetanus Neurotoxin‐Sensitive and Insensitive Routes to and from the Plasma Membrane: Fast and Slow Pathways? Traffic. 2005 May 31;6(5):366–73.
Osman C, Jennings R, El-Ghariani K, Pinto A. Plasma exchange in neurological disease. Pract Neurol. 2020 Apr;20(2):92–9.
Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, Al Khalili H, Memish Z. Therapeutic plasma exchange in adults with severe COVID-19 infection. International Journal of Infectious Diseases. 2020 Oct;99:214–8.
Foettinger F, Pilz G, Wipfler P, Harrer A, Kern JM, Trinka E, Moser T. Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders—A Pilot Study. Int J Mol Sci. 2023 Mar 31;24(7):6552.
Refbacks
- There are currently no refbacks.


